Gut Microbiota and Neurodevelopment in Infancy

Among infants in the Canadian Healthy Infant Longitudinal Development (CHILD) study, the bacterial composition of the gut at 12 months of age predicted cognitive, language, and motor performance at age 2. Babies whose late-infancy microbiomes were dominated by Bacteroides scored roughly 4–5 points higher on Bayley-III subscales than those with Proteobacteria-dominant microbiomes. The same microbial composition at 4 months showed no such association — a developmental-window finding that has reshaped how researchers think about when the gut-brain axis matters most for neurodevelopment.

The original observation came from Tamana and colleagues (2021) and has since been extended by metabolite-level analyses, large international cohorts, and even a randomized trial of vaginal microbial transfer. The picture that emerges is more nuanced than “good bugs help the brain.” Specific microbial taxa, specific developmental windows, specific cognitive domains, and — surprisingly — sex appear to interact in ways that the clinical literature is still working out.

The CHILD cohort finding in detail

Tamana et al. analyzed fecal samples from 405 infants in the CHILD cohort, collected at a mean age of 4 months and again at 12 months, and assessed neurodevelopment using the Bayley Scales of Infant Development, Third Edition (BSID-III) at 12 months and 24 months. At 12 months, the microbiomes clustered into three dominant patterns: Proteobacteria-dominant, Firmicutes-dominant, and Bacteroidetes-dominant.

Compared with the Proteobacteria-dominant cluster, infants in the Bacteroidetes-dominant cluster scored on average:

• +4.8 points on cognitive composite (FDR-adjusted p = .02)
• +4.2 points on language composite (FDR-adjusted p ≤ .001)
• +3.1 points on motor composite (FDR-adjusted p = .03)

Two findings made the result striking. First, the association was specific to late infancy — microbiome composition at 4 months showed no association with later Bayley scores, despite using the same clustering methodology. Second, the effect was largely driven by male infants. Sex-stratified analyses found that males in the Bacteroidetes-dominant cluster showed substantially larger cognitive and language gains than females in the same cluster, with the female-specific effect not reaching statistical significance.

At the genus level, the relative abundance of Bacteroides specifically (rather than the broader Bacteroidetes phylum) was positively correlated with cognitive and language scores. Functional analysis of the bacterial genomes pointed to enhanced sphingolipid synthesis and metabolism, plus an antagonistic relationship with Streptococcus abundance, as candidate mechanisms.

Why does the timing matter so much?

The asymmetry between 4-month and 12-month microbiomes maps onto the biology of microbial succession. Newborn microbiomes are dominated by maternally-transmitted strains and are heavily shaped by feeding pattern: breastfed infants have Bifidobacterium-dominated communities adapted to digesting human milk oligosaccharides, while formula-fed infants show earlier diversification. By 6–9 months, the introduction of solid food triggers a major successional shift: Bacteroides, Faecalibacterium, and other adult-pattern taxa expand as the diet introduces complex polysaccharides and fibers.

The 12-month microbiome therefore reflects how successfully an infant has navigated this dietary-immune-microbial transition. Children whose gut communities have not progressed past Proteobacteria-dominance by 12 months are in a slower or atypical developmental trajectory — and that trajectory itself, rather than any single microbe, may be what tracks with cognitive outcomes.

A 2025 follow-up analysis of the same CHILD cohort by Davias and colleagues took a metabolite-level look at the 3–4-month window. Using NMR-based metabolomics on infant fecal samples (n = 178), the team measured short-chain fatty acid concentrations and tested associations with Bayley-III cognitive scores at 24 months. The findings complicated the simple “early microbes don’t matter” reading: propionate and butyrate concentrations at 3–4 months were associated with lower 24-month cognitive scores, while lactate was associated with higher scores. Taxonomic clusters at 3–4 months still showed no association — but the underlying metabolic state did.

The reconciliation with Tamana’s null finding at 4 months is straightforward: microbial composition at 4 months is too unstable and too heterogeneous to cluster cleanly, but the metabolic signature reflects what the bacteria actually do, which can be informative even when taxonomy is noisy.

Upstream determinants: delivery mode and feeding

If late-infancy microbial composition predicts cognition, the next question is what shapes late-infancy composition. Two factors dominate:

Delivery mode. Vaginally-born infants are inoculated at birth with maternal vaginal and intestinal microbes, including the early Bacteroides strains that later dominate the post-weaning gut. Cesarean-born infants miss this exposure and are colonized initially by skin and environmental microbes, with delayed acquisition of Bacteroides-class anaerobes. The compositional gap between vaginal- and cesarean-delivered microbiomes narrows over the first year but does not fully close.

Feeding pattern. Breastfeeding promotes Bifidobacterium-dominated early communities, which in turn shape the later transition to Bacteroides-dominant patterns more reliably than formula feeding. The longer and more exclusive the breastfeeding, the more typical the post-weaning transition tends to be.

The 2024 Hickman et al. analysis of nearly 1,000 Finnish infants developed a “gut microbiota wellbeing index” — a composite measure combining diversity, age-appropriate maturation, and the absence of pathobiont blooms — and showed that the index predicted overall infant health outcomes more strongly than any single taxon. The index integrated delivery-mode and feeding signals into a developmental trajectory, consistent with the framing that maturation rather than composition at any single point is what matters.

The vaginal seeding question

If cesarean-delivered infants have altered microbial colonization that plausibly contributes to neurodevelopmental outcomes, the obvious clinical question is whether transferring maternal vaginal microbes to cesarean newborns can normalize trajectories. A 2023 triple-blind randomized controlled trial by Zhou and colleagues, published in Cell Host & Microbe, addressed this directly.

The trial randomized 68 cesarean-delivered infants to either vaginal microbiota transfer (VMT) — gauze swabbed in the maternal vaginal canal before delivery and then applied to the newborn’s mouth, face, and skin — or saline-soaked control gauze. The intervention was performed within minutes of birth in a triple-blind design (parents, clinicians, and outcome assessors all masked).

The neurodevelopmental outcome, measured by Ages and Stages Questionnaire (ASQ-3) at 6 months, was significantly higher in the VMT group than in the saline group. The ASQ-3 scores in the VMT group were comparable to those of separately-followed vaginally-delivered controls, suggesting partial normalization. Adverse events were not significantly different between groups, and microbiome analysis showed accelerated maturation toward a vaginal-delivery-like trajectory in VMT infants.

The trial is small and the follow-up short, but it is the first randomized evidence that altering early microbial exposure changes a behavioral neurodevelopmental outcome in human infants. The study has since prompted larger trials in multiple countries and a debate about whether the effect is mediated through gut microbiota or through skin microbiota — recent mouse work suggests both contribute.

Why the male-specific effect?

The sex-specific pattern in Tamana 2021 is not an isolated finding. Across multiple cohorts, microbiome-related associations with cognitive and behavioral outcomes are stronger or more reproducible in male infants. Several biological hypotheses are consistent with this pattern:

• Greater developmental fragility. Male infants are more vulnerable to a wide range of perinatal insults — preterm birth, hypoxia, infection — and the same vulnerability may amplify the consequences of suboptimal microbial colonization.
• Sex-differential immune development. Microbiota shape the neonatal immune system, and immune-system development differs by sex from the first weeks of life. Microbial perturbation may translate into more pronounced inflammatory differences in males.
• Hormonal interactions. Bile-acid metabolism and short-chain fatty acid signaling are modulated by androgens; the same microbial output may produce different downstream effects in male and female infants.

None of these mechanisms is settled, but the empirical pattern — sex-specific or sex-amplified microbiome-cognition associations — is reproducible enough that future cohort analyses should plan for sex-stratified reporting from the start.

What this evidence does and does not support

The Tamana 2021 finding is observational and cross-sectional within the cohort design, which sets clear limits on causal inference. Confounders that plausibly correlate with both Bacteroides-dominant late-infancy microbiomes and higher Bayley scores include parental education, household income, breastfeeding duration, dietary diversity at weaning, and exposure to nature and pets. The CHILD analysis adjusted for the obvious ones, but adjustment cannot fully correct for unmeasured family-level differences.

What the evidence does support, taken together with Davias 2025, Hickman 2024, and Zhou 2023:

• Microbial composition at late infancy is associated with subsequent cognitive, language, and motor outcomes.
• The earlier microbial state is informative when measured metabolically rather than taxonomically.
• Targeted perinatal microbial intervention (VMT) produces measurable short-term neurodevelopmental differences in randomized comparison.
• The strongest upstream levers are vaginal delivery (when feasible and safe) and breastfeeding, both of which act through microbial channels among other pathways.

What the evidence does not support is direct probiotic supplementation as a verified neurodevelopmental intervention. Despite a large commercial market for infant probiotics, there is no published randomized trial showing that a defined probiotic strain administered to healthy term infants improves Bayley-III or ASQ-3 outcomes. The neurodevelopmental signal in the literature comes from community-level microbial states, not single-strain interventions, and the latter have so far failed to reproduce the former’s associations.

Practical implications

For parents and clinicians, the actionable takeaways are modest and align with existing pediatric guidance.

• Prefer vaginal delivery when medically appropriate. The microbial benefits add to the well-established immediate maternal and neonatal benefits.
• Support breastfeeding when feasible. The microbiome-related effects compound with the nutritional and immunological benefits and shape the post-weaning transition that the late-infancy data point to.
• Avoid unnecessary perinatal and infant antibiotics. See the related discussion of [early-life antibiotic exposure and gut-brain axis effects](https://www.psychologic.online/2021/07/14/early-penicillin-gut-brain/).
• Hold off on commercial probiotic claims for cognitive benefit. The evidence supports protecting the developmental window, not buying a supplement to “boost” microbiome-mediated cognition.

For researchers, the highest-value next steps are (a) larger randomized trials of perinatal microbial intervention with neurodevelopmental endpoints, (b) sex-stratified analyses as a default rather than an afterthought, and (c) integration of taxonomic, metabolic, and immune readouts in the same cohorts so that the developmental-window biology can be characterized at the level of mechanism rather than just association.

The takeaway

Tamana et al. (2021) showed that the gut microbiome at 12 months of age — but not at 4 months — predicts cognitive, language, and motor outcomes at age 2, with effects strongest in males and driven by Bacteroides-dominant compositions. Subsequent work from the same cohort, large independent infant cohorts, and a randomized trial of vaginal microbial transfer have together built a coherent picture: late-infancy microbial maturation is a real and modifiable contributor to early neurodevelopment, mediated through metabolites and immune development, and most strongly shaped by the upstream determinants of delivery mode, feeding, and antibiotic exposure. The honest summary is small effects, real biology, and clear levers — none of which require a probiotic purchase.